(Q54435931)

English

Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.

scientific article published in January 1986

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

phase II clinical trial

0 references

gynecologic oncology

1 reference

based on heuristic

inferred from title

author name string

W P McGuire

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

J A Blessing

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

P J DiSaia

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

H J Buchsbaum

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

publication date

1 January 1986

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

Investigational New Drugs

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

49-52

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

https://scigraph.springernature.com/pub.10.1007/bf00172016

0 references

Phase II trial of acivicin in advanced metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acivicin. An antitumor antibiotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of acivicin in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy for mouse tumors and human tumor xenografts with the antitumor antibiotic AT-125

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acivicin: a new glutamine antagonist in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/3700040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00172016

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/3700040

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54435931&oldid=1531860915"